Bruce Booth's most recent trade in Kymera Therapeutics Inc was a trade of 16,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Sionna Therapeutics Inc. | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 19,959 | 19,959 | - | - | Non-Qualified Stock Option (right to buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 5,000 | 5,000 | - | 0 | Common Stock | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 48,393 | 48,393 | - | - | Stock Option Award (Right to Buy) | |
| Sionna Therapeutics Inc. | Bruce Booth | Director | 10 Feb 2025 | 2,886,293 | 2,886,293 | - | - | Common Stock | ||
| Sionna Therapeutics Inc. | Bruce Booth | Director | 10 Feb 2025 | 1,806,317 | 0 | - | - | Series A convertible preferred stock | ||
| Sionna Therapeutics Inc. | Bruce Booth | Director | 10 Feb 2025 | 1,298,332 | 0 | - | - | Series B convertible preferred stock | ||
| Sionna Therapeutics Inc. | Bruce Booth | Director | 10 Feb 2025 | 1,092,504 | 0 | - | - | Series C convertible preferred stock | ||
| Sionna Therapeutics Inc. | Bruce Booth | Director | 10 Feb 2025 | 1,051,051 | 0 | - | - | Series Seed convertible preferred stock | ||
| Sionna Therapeutics Inc. | Bruce Booth | Director | 10 Feb 2025 | 747,727 | 747,727 | - | - | Common Stock | ||
| Sionna Therapeutics Inc. | Bruce Booth | Director | 10 Feb 2025 | 61,463 | 0 | - | - | Series C convertible preferred stock | ||
| Sionna Therapeutics Inc. | Bruce Booth | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 10 Feb 2025 | 60,000 | 807,727 | - | 18 | 1,080,000 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 38.48 per share. | 09 Jul 2024 | 183,868 | 4,269,602 | - | 38.5 | 7,075,241 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 39.26 per share. | 09 Jul 2024 | 96,386 | 4,173,216 | - | 39.3 | 3,784,114 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 37.41 per share. | 09 Jul 2024 | 41,763 | 4,453,470 | - | 37.4 | 1,562,354 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 38.48 per share. | 09 Jul 2024 | 38,606 | 743,484 | - | 38.5 | 1,485,559 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 36.40 per share. | 09 Jul 2024 | 28,718 | 4,495,233 | - | 36.4 | 1,045,335 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 35.57 per share. | 09 Jul 2024 | 24,449 | 4,523,951 | - | 35.6 | 869,651 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 39.26 per share. | 09 Jul 2024 | 20,238 | 723,246 | - | 39.3 | 794,544 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 37.41 per share. | 09 Jul 2024 | 8,769 | 782,090 | - | 37.4 | 328,048 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 36.40 per share. | 09 Jul 2024 | 6,030 | 790,859 | - | 36.4 | 219,492 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 35.57 per share. | 09 Jul 2024 | 5,133 | 796,889 | - | 35.6 | 182,581 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 35.35 per share. | 12 Jun 2024 | 11,838 | 4,558,827 | - | 35.3 | 418,473 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 34.98 per share. | 12 Jun 2024 | 8,430 | 4,548,400 | - | 35.0 | 294,881 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 35.35 per share. | 12 Jun 2024 | 2,485 | 804,212 | - | 35.4 | 87,845 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 36.02 per share. | 12 Jun 2024 | 1,997 | 4,556,830 | - | 36.0 | 71,932 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 34.98 per share. | 12 Jun 2024 | 1,770 | 802,022 | - | 35.0 | 61,915 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 36.02 per share. | 12 Jun 2024 | 420 | 803,792 | - | 36.0 | 15,128 | Common Stock |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 18,068 | 18,068 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 13,928 | 13,928 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 13,928 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 12,155 | 12,155 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 12,155 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 9,713 | 9,713 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 9,713 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 7,577 | 7,577 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 7,577 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 40.62 per share. | 14 Mar 2024 | 49,591 | 4,572,258 | - | 40.6 | 2,014,386 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 39.73 per share. | 14 Mar 2024 | 34,473 | 4,641,602 | - | 39.7 | 1,369,612 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 40.66 per share. | 14 Mar 2024 | 10,846 | 4,630,756 | - | 40.7 | 440,998 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 40.62 per share. | 14 Mar 2024 | 10,411 | 807,026 | - | 40.6 | 422,895 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 39.31 per share. | 14 Mar 2024 | 8,126 | 4,621,849 | - | 39.3 | 319,433 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 39.73 per share. | 14 Mar 2024 | 7,292 | 821,538 | - | 39.7 | 289,711 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 40.66 per share. | 14 Mar 2024 | 2,233 | 819,305 | - | 40.7 | 90,794 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 39.31 per share. | 14 Mar 2024 | 1,714 | 817,437 | - | 39.3 | 67,377 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 41.23 per share. | 14 Mar 2024 | 1,593 | 4,570,665 | - | 41.2 | 65,679 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 41.51 per share. | 14 Mar 2024 | 781 | 4,629,975 | - | 41.5 | 32,419 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 41.23 per share. | 14 Mar 2024 | 329 | 806,697 | - | 41.2 | 13,565 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 41.51 per share. | 14 Mar 2024 | 154 | 819,151 | - | 41.5 | 6,393 | Common stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 41.94 per share. | 11 Mar 2024 | 126,066 | 4,799,746 | - | 41.9 | 5,287,208 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 42.19 per share. | 11 Mar 2024 | 108,404 | 4,682,761 | - | 42.2 | 4,573,565 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 42.77 per share. | 11 Mar 2024 | 37,180 | 4,930,934 | - | 42.8 | 1,590,189 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 41.94 per share. | 11 Mar 2024 | 26,452 | 854,814 | - | 41.9 | 1,109,397 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 42.19 per share. | 11 Mar 2024 | 22,779 | 830,216 | - | 42.2 | 961,046 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 42.52 per share. | 11 Mar 2024 | 8,581 | 4,791,165 | - | 42.5 | 364,864 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 42.77 per share. | 11 Mar 2024 | 7,837 | 882,311 | - | 42.8 | 335,188 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 42.84 per share. | 11 Mar 2024 | 6,686 | 4,676,075 | - | 42.8 | 286,428 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 43.42 per share. | 11 Mar 2024 | 5,122 | 4,925,812 | - | 43.4 | 222,397 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 42.52 per share. | 11 Mar 2024 | 1,819 | 852,995 | - | 42.5 | 77,344 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 42.84 per share. | 11 Mar 2024 | 1,386 | 828,830 | - | 42.8 | 59,376 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 43.42 per share. | 11 Mar 2024 | 1,045 | 881,266 | - | 43.4 | 45,374 | Common Stock |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 34,612 | 34,612 | - | - | Stock Option Grant (Right to Buy) | |
| Kymera Therapeutics Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 13,928 | 13,928 | - | - | Stock Option Grant (Right to Buy) | |
| Tectonic Therapeutic Inc. | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 17,643 | 17,643 | - | - | Stock Option (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 9,713 | 9,713 | - | - | Stock Option Grant (Right to Buy) | |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.29 per share. | 11 Jan 2023 | 77,128 | 4,968,114 | - | 30.3 | 2,336,207 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 29.96 per share. | 11 Jan 2023 | 21,683 | 5,045,242 | - | 30.0 | 649,623 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.29 per share. | 11 Jan 2023 | 21,592 | 890,148 | - | 30.3 | 654,022 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 29.96 per share. | 11 Jan 2023 | 6,071 | 911,740 | - | 30.0 | 181,887 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.28 per share. | 14 Dec 2022 | 112,819 | 5,252,744 | - | 30.3 | 3,416,159 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 31.44 per share. | 14 Dec 2022 | 101,189 | 5,151,555 | - | 31.4 | 3,181,382 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 32.33 per share. | 14 Dec 2022 | 54,737 | 5,096,818 | - | 32.3 | 1,769,647 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.28 per share. | 14 Dec 2022 | 31,584 | 969,833 | - | 30.3 | 956,364 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 31.44 per share. | 14 Dec 2022 | 28,329 | 941,504 | - | 31.4 | 890,664 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 32.33 per share. | 14 Dec 2022 | 15,324 | 926,180 | - | 32.3 | 495,425 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 33.34 per share. | 14 Dec 2022 | 13,997 | 5,082,821 | - | 33.3 | 466,660 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 34.02 per share. | 14 Dec 2022 | 13,335 | 5,069,486 | - | 34.0 | 453,657 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 33.34 per share. | 14 Dec 2022 | 3,919 | 922,261 | - | 33.3 | 130,659 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 34.02 per share. | 14 Dec 2022 | 3,733 | 918,528 | - | 34.0 | 126,997 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 14 Dec 2022 | 2,561 | 5,066,925 | - | 30 | 76,830 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 14 Dec 2022 | 717 | 917,811 | - | 30 | 21,510 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.02 per share. | 02 Nov 2022 | 96,581 | 5,440,875 | - | 30.0 | 2,899,362 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 02 Nov 2022 | 75,312 | 5,365,563 | - | 30 | 2,259,360 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.02 per share. | 02 Nov 2022 | 27,038 | 1,022,502 | - | 30.0 | 811,681 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 02 Nov 2022 | 21,085 | 1,001,417 | - | 30 | 632,550 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.23 per share. | 28 Oct 2022 | 94,239 | 5,597,638 | - | 30.2 | 2,848,845 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 28 Oct 2022 | 71,135 | 5,691,877 | - | 30 | 2,134,050 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.57 per share. | 28 Oct 2022 | 56,455 | 5,541,183 | - | 30.6 | 1,725,829 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.23 per share. | 28 Oct 2022 | 26,383 | 1,066,388 | - | 30.2 | 797,558 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 28 Oct 2022 | 19,915 | 1,092,771 | - | 30 | 597,450 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 30.57 per share. | 28 Oct 2022 | 15,804 | 1,050,584 | - | 30.6 | 483,128 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 31.08 per share. | 28 Oct 2022 | 3,727 | 5,537,456 | - | 31.1 | 115,835 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Sale of securities on an exchange or to another person at price $ 31.08 per share. | 28 Oct 2022 | 1,044 | 1,049,540 | - | 31.1 | 32,448 | Common Stock |
| Kymera Therapeutics Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 12,155 | 12,155 | - | - | Stock Option Grant (Right to Buy) | |
| Tectonic Therapeutic Inc. | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc. | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 7,577 | 7,577 | - | - | Stock Option Grant (Right to Buy) | |
| Vigil Neuroscience Inc | Bruce Booth | Director | 11 Jan 2022 | 7,852,374 | 0 | - | - | Series A Preferred Stock |